Live Attenuated Vaccines Interactions

Avoid live attenuated vaccines during and for 2 months after fingolimod treatment due to risk of infection from immunosuppression.

Source: NLP:fingolimod

Should not be administered within 2 weeks before or 48 hours after amantadine hydrochloride unless medically indicated due to potential antiviral interference with vaccine replication.

Source: NLP:amantadine hydrochloride

Oseltamivir may inhibit replication of live vaccine virus and reduce LAIV efficacy. Avoid LAIV administration within 2 weeks before or 48 hours after oseltamivir use unless medically indicated.

Source: NLP:oseltamivir phosphate

Corticosteroids may potentiate replication of organisms in live attenuated vaccines and suppress antibody response; routine vaccination should be deferred until therapy discontinued.

Source: NLP:prednisolone sodium phosphate

LAIV should not be administered within 2 weeks before or 48 hours after amantadine due to potential interference with vaccine virus replication.

Source: NLP:amantadine

Oseltamivir may inhibit replication of live vaccine virus and reduce efficacy of LAIV. Avoid LAIV administration within 2 weeks before or 48 hours after oseltamivir use unless medically indicated.

Source: NLP:oseltamivir

Potential interference between products. LAIV should not be administered until 48 hours after rimantadine cessation; rimantadine should not be given until 2 weeks after LAIV unless medically indicated.

Source: NLP:rimantadine hydrochloride

LAIV should not be administered within 2 weeks before or 48 hours after RELENZA administration due to potential interference. Antiviral drugs may inhibit replication of live vaccine virus.

Source: NLP:zanamivir